Ranked #712 of 8,699 institutional investors
Regents Of The University Of California
Oakland, CA
$6.11B
US stock portfolio at live prices · today −$157.6M (−2.51%)
Live prices, last trade 12:56 PM ET
- Value at quarter end (Q3 2026)
- $6.64B
- Change from Q2 2026
- +$2.28B (+52.16%)
- Positions
- 10 · 3 new, 2 sold out
- Filed
- Oct 26, 2026
Not counted in the ranking: none$636M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesUCBG 38.0%STT 25.5%SPCX 13.0%OTF 5.74%BN 5.59%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| UCBG State Street(R) SPDR(R) Uc Investments 90/10 Endowment Strategy Index ETF | 49,795,937 | $2.32B | 38.0% | New |
| STT State Street Corporation | 9,874,043 | $1.56B | 25.5% | Reduced −0% |
| SPCX Space Exploration Technologies Corp. | 6,189,218 | $794M | 13.0% | Added +3% |
| OTF Blue Owl Technology Finance Corp. | 38,861,215 | $351M | 5.74% | Reduced −11% |
| BN Brookfield Corporation | 8,979,204 | $342M | 5.59% | Unchanged |
| GLDM SPDR Gold MiniShares | 1,438,678 | $100M | 1.64% | Unchanged |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2,509,446 | $4.5M | <0.1% | New |
| SRZN Surrozen, Inc. | 133,207 | $3.9M | <0.1% | Unchanged |
| EIKN Eikon Therapeutics, Inc. | 635,131 | $3.1M | <0.1% | New |
| OWL Blue Owl Capital Inc. | 66,346 | $586K | <0.1% | Unchanged |